2breathe Technologies Ltd.

2breathe Technologies Ltd. is a pioneering company in the digital therapeutic devices field, focusing on hypertension and sleeplessness. Their flagship product, RESPeRATE®, is the world’s first FDA-cleared, non-drug hypertension treatment device, endorsed by the American Heart Association. The company has expanded its portfolio with 2breathe™, utilizing the same guided-breathing technology to aid individuals struggling with sleep issues. Based in Israel, 2breathe Technologies Ltd. leverages innovative technology to address prevalent health concerns. Currently, there is no publicly disclosed information about their latest investment round or associated investors. As the company continues to make strides in the digital therapeutic devices sector, they present a compelling opportunity for potential investors seeking to tap into the burgeoning market of non-pharmacological treatments.